Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance

被引:6
|
作者
Kim, Seon Young [1 ,2 ]
Im, Kyongok [3 ]
Park, Si Nae [3 ]
Kim, Jung-Ah [1 ]
Yoon, Sung-Soo [3 ,4 ]
Lee, Dong Soon [1 ,3 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Lab Med, 101 Daehak Ro, Seoul 110744, South Korea
[2] Chungnam Natl Univ, Coll Med, Dept Lab Med, Daejeon, South Korea
[3] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
基金
新加坡国家研究基金会;
关键词
AL amyloidosis; Monoclonal gammopathy of undermined significance; Multiple myeloma; Cytogenetics; IN-SITU HYBRIDIZATION; HIGH-DOSE MELPHALAN; MULTIPLE-MYELOMA; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; AL AMYLOIDOSIS; SYSTEMIC AMYLOIDOSIS; GENETIC EVENTS; TRANSPLANTATION; TRANSLOCATIONS;
D O I
10.1016/j.leukres.2016.03.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We performed cytoplasmic fluorescence in situ hybridization assays of light chain amyloidosis (AL). In total, 234 patients were enrolled: 28 patients with AL, 24 with monoclonal gammopathy of undetermined significance (MGUS), and 182 with multiple myeloma (MM). Chromosomal abnormalities were detected in 13 of 22 (59%) AL patients without MM. All 13 patients demonstrated IGH rearrangement, and t(11;14)1IGH-CCND1 was most frequent (32%). Chromosome gain was not observed in AL patients without MM. These findings were dissimilar to findings in MGUS patients, in whom trisomy 9 was the most frequent abnormality. Of 6 AL patients with MM, 5 (83%) patients had cytogenetic abnormalities: lq gain (4/6, 67%), gains of chromosome 9 (3/6, 50%), IGH rearrangement and RBI (13q) deletions (2/6 each, 33%). The percentage of clonal plasma cells among total plasma cells was variable (median, 75%; range, 16-100%) for AL patients without MM, which was lower than the results for MM patients (median 100%). The overall survival of AL patients without MM was not significantly different according to the presence of cytogenetic abnormalities (13= 0.510). In summary, among Korean AL patients, IGH rearrangement was the most frequent cytogenetic abnormality and cytogenetic aberration patterns differ compared with MGUS and MM patients. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [1] Association of abnormal molecular markers with clonal plasma cell burden in light chain amyloidosis.
    Hammons, Lindsay
    Hari, Parameswaran
    Brazauskas, Ruta
    D'Souza, Anita
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Bone marrow plasma cell light chain k/λ ratio values have prognostic relevance in AL amyloidosis
    Perfetti, V
    Vignarelli, MC
    Anesi, E
    Garini, P
    Quaglini, S
    Ubbiali, P
    Ascari, E
    Merlini, G
    AMYLOID AND AMYLOIDOSIS 1998, 1999, : 118 - 120
  • [3] Prognostic factors in light chain amyloidosis
    Javorniczky Nora Rebeka
    Bodo Imre
    Masszi Tamas
    Mikala Gabor
    ORVOSI HETILAP, 2015, 156 (39) : 1577 - 1584
  • [4] Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis
    Sidana, Surbhi
    Tandon, Nidhi
    Dispenzieri, Angela
    Gertz, Morie A.
    Dingli, David
    Jevremovic, Dragan
    Morice, William G.
    Kapoor, Prashant
    Kourelis, Taxiarchis V.
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Leung, Nelson
    Go, Ronald S.
    Lin, Yi
    Russell, Stephen J.
    Lust, John A.
    Zeldenrust, Steven R.
    Warsame, Rahma
    Hwa, Yi L.
    Hobbs, Miriam
    Fonder, Amie
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    Gonsalves, Wilson I.
    LEUKEMIA, 2018, 32 (06) : 1421 - 1426
  • [5] Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis
    Surbhi Sidana
    Nidhi Tandon
    Angela Dispenzieri
    Morie A. Gertz
    David Dingli
    Dragan Jevremovic
    William G. Morice
    Prashant Kapoor
    Taxiarchis V. Kourelis
    Martha Q. Lacy
    Suzanne R. Hayman
    Francis K. Buadi
    Nelson Leung
    Ronald S. Go
    Yi Lin
    Stephen J. Russell
    John A. Lust
    Steven R. Zeldenrust
    Rahma Warsame
    Yi L. Hwa
    Miriam Hobbs
    Amie Fonder
    Robert A. Kyle
    S. Vincent Rajkumar
    Shaji K. Kumar
    Wilson I. Gonsalves
    Leukemia, 2018, 32 : 1421 - 1426
  • [6] The genomic landscape of plasma cells in systemic light chain amyloidosis
    Boyle, Eileen M.
    Ashby, Cody
    Wardell, Christopher P.
    Rowczenio, Dorota
    Sachchithanantham, Sajitha
    Wang, Yan
    Johnson, Sarah K.
    Bauer, Michael A.
    Weinhold, Niels
    Kaiser, Martin F.
    Johnson, David C.
    Jones, John R.
    Pawlyn, Charlotte
    Proszek, Paula
    Schinke, Carolina
    Facon, Thierry
    Dumontet, Charles
    Davies, Faith E.
    Morgan, Gareth J.
    Walker, Brian A.
    Wechalekar, Ashutosh D.
    BLOOD, 2018, 132 (26) : 2775 - 2777
  • [7] A Novel Prognostic Staging System for Light Chain Amyloidosis (AL) Incorporating Markers of Plasma Cell Burden and Organ Involvement.
    Kumar, Shaji
    Dispenzieri, Angela
    Lacy, Martha Q.
    Hayman, Suzzane
    Buadi, Francis
    Zeldenrust, Steven R.
    Leung, Nelson
    Ramirez-Alvarado, Marina
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Gertz, Morie A.
    BLOOD, 2009, 114 (22) : 1094 - 1094
  • [8] Prognostic Significance of Circulating Plasma Cells Detected By Next Generation Flow Cytometry in Light (AL) Chain Amyloidosis
    Kastritis, Efstathios
    Kostopoulos, Ioannis, V
    Theodorakakou, Foteini
    Roussakis, Pantelis
    Panteli, Chrysanthi
    Orologas-Stavrou, Nikolaos
    Spiliopoulou, Vasiliki
    Migkou, Magdalini
    Papanikolaou, Asimina
    Gakiopoulou, Harikleia
    Fotiou, Despina
    Terpos, Evangelos
    Tsitsilonis, Ourania E.
    Dimopoulos, Meletios A.
    BLOOD, 2022, 140 : 1150 - 1151
  • [9] Prognostic Value of Holter Monitoring in Light Chain Amyloidosis
    Sun, Yutong
    Zhao, Qinghao
    Liu, Yang
    Wen, Lei
    Dou, Xuelin
    Lu, Jin
    Liu, Jian
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [10] Light Chain Amyloidosis Plasma Cells Show Specific Chromatin Accessibility and Transcriptome
    Ariceta, Benat
    Nevone, Alice
    Cenzano, Itziar
    Amundarain, Ane
    Vilas-Zornoza, Amaia
    Garate, Leire
    Aguirre-Ruiz, Paula
    Miranda, Estibaliz
    San-Martin, Patxi
    Milani, Paolo
    Lecumberri Villamediana, Ramon
    Alignani, Diego
    Palladini, Giovanni
    Paiva, Bruno
    Martin-Subero, Jose Ignacio
    Merlini, Giampaolo
    San-Miguel, Jesus
    Hernaez, Mikel
    Gomez-Cabrero, David
    Agirre, Xabier
    Nuvolone, Mario
    Prosper, Felipe
    BLOOD, 2023, 142